insights_auto
Outlook: 44.4% bullish·0.0% bearish
Go to analysischevron_right
TEM:NASDAQ
Tempus AI Inc
$76.59
arrow_downward
-0.78%(-0.60) 1D
$76.18
arrow_downward
-0.54% (-0.41)bedtimeAfter hours
Closed: Sep 23, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TEM...
Open
$76.47
High
$78.97
Low
$75.88
Mkt. cap
13.82B
Avg. vol.
7.60M
Volume
5.38M
52-wk high
$104.32
52-wk low
$40.77
EPS
-$1.43
Shares outstanding
175.39M
No. of employees
4K
Open
$76.47
High
$78.97
Low
$75.88
Mkt. cap
13.82B
Avg. vol.
7.60M
Volume
5.38M
52-wk high
$104.32
52-wk low
$40.77
EPS
-$1.43
Shares outstanding
175.39M
No. of employees
4K
News stories
From web sources and news partners
Investing.com
·
15 minutes ago
Cathie Wood’s ARK sells Tempus AI stock, buys Scribe Therapeutics
Benzinga
·
6 hours ago
10 Health Care Stocks Whale Activity In Today’s Session
Seeking Alpha
·
1 day ago
Tempus AI: High Risk, But With A Great Cause (NASDAQ:TEM)
Seeking Alpha
·
1 day ago
Tempus AI: Data And Applications Will Unlock More Upside (NASDAQ:TEM)
Profile
Tempus AI, Inc. is an American health technology company founded in 2015 by Eric Lefkofsky in Chicago, Illinois. It was established by Lefkofsky soon after his wife was diagnosed with breast cancer. Tempus uses data and artificial intelligence to create precision medicine services, including diagnostics, for oncology, cardiology, radiology, and depression. The company went public on the Nasdaq on June 14, 2024, under the ticker symbol "TEM." Wikipedia
About Tempus AI Inc
CEOEric Lefkofsky
Employees3.8K
Founded2015
HeadquartersChicago, Illinois, United States
SectorHealth care
Websitetempus.com